Post-effective Amendment to Registration Statement (pos Am)

Date : 05/17/2019 @ 9:37PM
Source : Edgar (US Regulatory)
Stock : Invivo Therapeutics Holdings Corp. (MM) (NVIV)
Quote : 0.72  0.0 (0.00%) @ 1:00AM

Post-effective Amendment to Registration Statement (pos Am)

As filed with the Securities and Exchange Commission on May 17, 2019

Registration No. 333-222738

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

POST-EFFECTIVE AMENDMENT NO. 2 TO

 

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

INVIVO THERAPEUTICS HOLDINGS CORP.

(Exact name of registrant as specified in its charter)

 

Nevada

 

3841

 

36-4528166

(State of incorporation)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer

Identification Number)

 

One Kendall Square, Suite B14402

Cambridge, MA 02139

(617) 863-5500

(Address, including zip code and telephone number, including area code, of Registrant’s principal executive offices)

 

Richard Toselli, M.D.

Chief Executive Officer

InVivo Therapeutics Holdings Corp.

One Kendall Square, Suite B14402

Cambridge, MA 02139

(617) 863-5500

(Name, address, including zip code and telephone number, including area code, of agent for service)

 

Copies to:

 

 

 

 

Rosemary G. Reilly, Esq.
Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street

Boston, Massachusetts 02109

(617) 526-6000

 

Approximate date of commencement of proposed sale to the public: Not applicable.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. 

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. 

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. 

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer 

 

Accelerated filer 

 

Non-accelerated filer 

 

Smaller reporting company 

Emerging growth company 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. 

 

 

 


 

 

DEREGISTRATION OF UNSOLD SECURITIES

This Post-Effective Amendment No. 2 relates to the Registration Statement on Form S-1 (File No. 333-222738) (the “Registration Statement”) of InVivo Therapeutics Holdings Corp. (the “Company”) pertaining to the resale of shares of the Company’s common stock held by the selling stockholder listed therein (the “Selling Stockholder”), which was filed with the Securities and Exchange Commission on February 9, 2018 and became effective on February 12, 2018.

The Company’s contractual obligation to maintain the effectiveness of this Registration Statement with respect to the shares of common stock held by the Selling Stockholder has terminated, and the Company wishes to discontinue the effectiveness of this Registration Statement. As a result and pursuant to the Company’s undertaking in Item 17 of Part II of this Registration Statement, the Company hereby removes from registration any and all securities registered under this Registration Statement that remain unsold as of the date hereof and terminates the effectiveness of the Registration Statement.  The Registration Statement is hereby amended to reflect the deregistration of such unsold securities.

 

 

 

 


 

 

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Cambridge, Commonwealth of Massachusetts, on May 17, 2019.

 

INVIVO THERAPEUTICS HOLDINGS CORP.

 

 

 

 

 

 

 

By:

/s/ Richard Toselli

 

 

Richard Toselli

 

 

President and Chief Executive Officer

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment to the Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

 

 

 

 

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Richard Toselli

 

Chief Executive Officer and Director (Principal

 

May 17, 2019

Richard Toselli

 

Executive Officer

 

 

 

 

 

 

 

/s/ Richard Christopher

 

Principal Financial Officer (Principal Financial

 

May 17, 2019

Richard Christopher

 

And Accounting Officer)

 

 

 

 

 

 

 

*

 

Director

 

May 17, 2019

C. Ann Merrifield

 

 

 

 

 

 

 

 

 

*

 

Director

 

May 17, 2019

Daniel R. Marshak

 

 

 

 

 

 

 

 

 

*

 

Director

 

May 17, 2019

Christina Morrison

 

 

 

 

 

 

 

 

 

*

 

Director

 

May 17, 2019

Richard Roberts

 

 

 

 

 

 

 

 

* By:

/s/ Richard Toselli

 

Richard Toselli

Attorney-in-Fact

 

 


InVivo Therapeutics Holdings (NASDAQ:NVIV)
Historical Stock Chart

1 Year : From Jun 2018 to Jun 2019

Click Here for more InVivo Therapeutics Holdings Charts.

InVivo Therapeutics Holdings (NASDAQ:NVIV)
Intraday Stock Chart

Today : Tuesday 18 June 2019

Click Here for more InVivo Therapeutics Holdings Charts.

Latest NVIV Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.